Suchergebnisse - (Standardsuche:ritonavir)

PubPharm (22.319)

1

Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir

enthalten in: Nature microbiology | 2024

von Chen, X. | Huang, X. | Ma, Q. | +30

2

Proof-of-concept studies with a computationally designed Mpro inhibitor as a synergistic combination regimen alternative to Paxlovid

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Papini, C. | Ullah, I. | Ranjan, A. | +11

3

Correction : SARS-CoV-2 Virologic Rebound With Nirmatrelvir-Ritonavir Therapy

enthalten in: Annals of internal medicine | 2024

ErratumFor: Ann Intern Med. 2023 Dec;176(12):1577-1585. - PMID 37956428

4

Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters

enthalten in: Clinical and translational science | 2024

von Ho, Y. | Gorycki, P. | Ferron-Brady, G. | +2

5

A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound

enthalten in: bioRxiv.org | 2024

von Esmaeili-Wellman, S. | Owens, K. | Wagoner, J. | +3

6

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis : Open Label Phase 2 Clinical Study of Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

enthalten in: ClinicalTrials.gov | 2024

7

Hemorrhagic cystitis induced by JC polyomavirus infection following COVID-19 : a case report

enthalten in: BMC urology | 2024

von Lv, Y. | Liu, X.

8

Hemorrhagic cystitis induced by JC polyomavirus infection following COVID-19: a case report

enthalten in: BMC urology | 2024

von Lv, Y. | Liu, X.

9

CHAPAS-4 trial: second-line anchor drugs for children with HIV in Africa

enthalten in: bioRxiv.org | 2024

von Bwakura-Dangarembizi, M. | Szubert, A. | Mumbiro, V. | +24

10

Physiologically-based pharmacokinetic modelling guided dose evaluations of nirmatrelvir/ritonavir in renal impairment for the management of COVID-19

enthalten in: British journal of clinical pharmacology | 2024

von Ng, T. | Wang, Z. | Chan, E.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2232]